| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥24.7B | ¥20.6B | +19.9% |
| Operating Income | ¥-8.6B | ¥-2.9B | -197.2% |
| Ordinary Income | ¥-9.5B | ¥-3.2B | -201.0% |
| Net Income | ¥-43.7B | ¥-4.0B | -994.2% |
| ROE | -594.8% | -27.0% | - |
FY2025 Q3 cumulative results reported revenue of 24.7B yen (YoY +19.9%), operating loss of 8.6B yen (YoY -197.2%), ordinary loss of 9.5B yen (YoY -201.0%), and net loss of 43.7B yen (YoY -994.2%). The revenue growth of 19.9% was driven by the full consolidation of newly acquired Medical segment operations and contributions from Renewable Energy segment expansion. Despite maintaining a high gross margin of 71.6%, the company posted a substantial operating loss as SG&A expenses of 26.3B yen exceeded revenue at 106.6% of sales. The operating margin deteriorated significantly from -14.1% to -34.9%. A major impairment loss of 33.5B yen recorded as extraordinary loss, primarily related to store assets in the Restaurant segment and reassessment of goodwill and intangible assets following business integration, resulted in the substantial net loss expansion from 4.0B yen to 43.7B yen. Total assets increased to 50.9B yen while equity declined sharply to 7.3B yen, resulting in an equity ratio of 14.4% and debt-to-equity ratio of 5.93, indicating severe financial strain. Basic EPS deteriorated to -78.10 yen from -7.75 yen.
Revenue increased 4.1B yen or 19.9% to 24.7B yen, driven by full-period consolidation of the Medical segment following the August 2024 acquisition of BOBS Co., Ltd. and Kaihan Medical Co., Ltd., which contributed 4.5B yen in revenue, and expansion of the Renewable Energy segment to 1.6B yen from 0.5B yen. The Restaurant segment, the largest business at 75.6% of total revenue, recorded relatively flat growth to 18.7B yen from 18.3B yen (YoY +2.0%). Gross profit increased to 17.7B yen from 15.1B yen, maintaining a strong gross margin of 71.6% compared to 73.2% in the prior year. However, operating income deteriorated significantly as SG&A expenses surged to 26.3B yen from 18.0B yen (YoY +46.1%), exceeding revenue at 106.6% of sales. The SG&A increase was driven by unallocated corporate expenses of 4.1B yen associated with business expansion and integration costs from newly consolidated subsidiaries. Operating loss expanded from 2.9B yen to 8.6B yen, representing a deterioration of 5.7B yen. Non-operating expenses increased to 1.3B yen from 0.3B yen, primarily due to interest expense of 1.3B yen (up from 0.2B yen), reflecting increased borrowings to finance acquisitions and working capital needs. Ordinary loss expanded from 3.2B yen to 9.5B yen. The gap between ordinary loss and net loss was driven by extraordinary items: negative goodwill of 0.4B yen (gain) was offset by an impairment loss of 33.5B yen, resulting in net extraordinary loss of 33.5B yen. The impairment primarily relates to store assets in the Restaurant segment and writedowns of goodwill and intangible assets from previous acquisitions. Income tax expense remained minimal at 0.7B yen despite the pretax loss of 43.0B yen, as tax benefits from loss carryforwards may not be fully recognizable given financial uncertainty. This represents a revenue up/profit down pattern, with top-line growth from M&A-driven expansion failing to translate into profitability due to cost structure challenges and non-recurring impairment charges.
The Restaurant segment generated revenue of 18.7B yen and operating loss of 0.1B yen (operating margin -0.5%), deteriorating from operating profit of 1.3B yen in the prior year as store-level performance weakened and a 0.3B yen impairment loss was recognized. This segment represents the core business at 75.6% of consolidated revenue. The Medical segment, newly consolidated from mid-FY2024, contributed revenue of 4.5B yen but recorded operating loss of 0.2B yen (operating margin -4.0%), reflecting startup costs and integration expenses during the initial consolidation period. The Renewable Energy segment generated revenue of 1.6B yen but posted operating loss of 1.8B yen (operating margin -116.6%), representing the worst performing segment as substantial upfront investment costs and development expenses preceded revenue generation. After adjusting for intersegment eliminations and unallocated corporate expenses of 4.1B yen, consolidated operating loss was 8.6B yen. The high corporate cost burden averaging 16.6% of revenue indicates significant overhead drag on segment profitability. All three segments reported negative operating income, with the Renewable Energy segment showing the most severe margin pressure due to its early-stage development profile.
[Profitability] ROE was -594.8%, sharply deteriorating from an already negative prior year level, driven by the 43.7B yen net loss against average equity of approximately 11.1B yen. Operating margin was -34.9%, down from -14.1%, as SG&A expenses at 106.6% of revenue significantly exceeded the industry-normal range. Net profit margin of -177.0% reflects both structural operating losses and non-recurring impairment charges. Gross margin remained relatively stable at 71.6% versus 73.2%, indicating pricing power and cost control at the product level are maintained. [Cash Quality] Cash and deposits stood at 4.2B yen, providing coverage of only 0.32x against short-term borrowings of 12.9B yen, indicating acute liquidity pressure. Operating working capital was negative 19.2B yen, with trade receivables of 3.4B yen and trade payables of 2.5B yen. [Investment Efficiency] Total asset turnover was 0.485, significantly below the retail industry median of 0.95, reflecting low efficiency in asset utilization. Property, plant and equipment increased to 24.4B yen from 15.2B yen, but construction in progress remained high at 6.0B yen, suggesting capital deployment has yet to generate proportional returns. [Financial Health] Equity ratio was 14.4%, down from 32.3%, indicating severe deterioration in financial stability. Current ratio was 43.6%, well below the critical 100% threshold, with current assets of 14.9B yen insufficient to cover current liabilities of 34.1B yen. Debt-to-equity ratio was 5.93, reflecting extremely high financial leverage. Interest-bearing debt totaled 21.7B yen, with short-term borrowings of 12.9B yen representing 59.4% of total debt, creating refinancing risk. Interest coverage ratio was -6.60x, as operating income was insufficient to cover interest expense of 1.3B yen.
Cash and deposits decreased 0.9B yen YoY to 4.2B yen despite revenue growth, indicating operational cash consumption and significant investment outlays. The operating loss of 8.6B yen combined with interest expense of 1.3B yen suggests substantial cash outflow from operating activities, although partial mitigation may have occurred through working capital adjustments as trade payables increased 1.3B yen (up 107.2%). Investing activities likely consumed significant cash, as property, plant and equipment increased 9.2B yen YoY to 24.4B yen and construction in progress rose 3.4B yen, reflecting capital expenditures for business expansion and new facilities. Goodwill decreased 13.5B yen and intangible assets declined 13.2B yen, primarily through non-cash impairment charges rather than cash recovery. Financing activities show short-term borrowings increased 5.5B yen to 12.9B yen, providing critical liquidity to fund operations and investments. Long-term loans payable stood at 8.8B yen, up from previous levels, indicating debt-financed expansion. The combination of operating cash consumption, high capital expenditure, and increased borrowing dependence has compressed cash coverage of short-term liabilities to 0.32x, indicating working capital stress and heightened refinancing risk as the company enters a period requiring either operational improvement or additional external funding.
Ordinary loss of 9.5B yen versus operating loss of 8.6B yen shows net non-operating expense of approximately 0.9B yen, primarily comprising interest expense of 1.3B yen partially offset by non-operating income of 0.4B yen. Non-operating income represents 1.6% of revenue and consists of minor financial income and other items. The negative contribution from non-operating items reflects the burden of increased debt servicing costs following acquisition-related borrowings. Extraordinary items had a substantial impact on bottom-line results, with extraordinary loss of 33.5B yen driven overwhelmingly by impairment loss of 33.5B yen, partially offset by negative goodwill (bargain purchase gain) of 0.4B yen. The impairment relates to store-level fixed assets in the Restaurant segment and reassessment of acquired goodwill and intangible assets. This extraordinary loss is classified as non-recurring, though it signals underlying asset quality concerns and potential overvaluation of past acquisitions. Earnings quality is weak at the operating level, as operating loss before impairment already exceeded 8.6B yen due to revenue-exceeding SG&A expenses. The substantial write-off of intangible assets (goodwill down 84.8%, intangibles down 80.5%) indicates that historical M&A investments have not delivered expected returns. Without cash flow statement data, direct verification of operating cash generation is unavailable, but the combination of operating losses, increased borrowings, and declining cash balances suggests that reported losses are cash-depleting. Earnings quality warrants concern due to both structural unprofitability and significant non-recurring charges.
Liquidity crisis risk: The current ratio of 43.6% and cash coverage of short-term borrowings at 0.32x indicate severe short-term liquidity constraints. With current liabilities of 34.1B yen against current assets of only 14.9B yen, the company faces a 19.2B yen shortfall in working capital. Short-term borrowings of 12.9B yen require refinancing within one year, and failure to secure rollover or new financing could trigger default or forced asset sales. Monthly cash burn from operating losses and interest payments of over 1B yen annually requires immediate attention.
High financial leverage and debt servicing risk: Debt-to-equity ratio of 5.93 and total interest-bearing debt of 21.7B yen against equity of only 7.3B yen create substantial financial fragility. Interest coverage is deeply negative at -6.60x, meaning operating income cannot cover interest expense of 1.3B yen. With operating losses persisting, the company is dependent on continued lender support and may face covenant breaches, increased borrowing costs, or inability to refinance maturing debt, particularly the 12.9B yen in short-term borrowings.
Business execution and asset impairment risk: The 33.5B yen impairment loss indicates significant overvaluation of acquired assets and underperformance of business integration, particularly in the Medical and Renewable Energy segments which are loss-making. SG&A expenses at 106.6% of revenue and unallocated corporate costs of 4.1B yen suggest structural inefficiency. Without successful turnaround of the Restaurant segment margin (-0.5%), acceleration of Medical segment profitability (-4.0% margin), and resolution of Renewable Energy losses (-116.6% margin), further asset impairments and equity erosion are likely. Failure to achieve breakeven within two to three quarters could jeopardize going concern status.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin -34.9% (Industry Median 3.9%), Net profit margin -177.0% (Industry Median 2.2%), ROE -594.8% (Industry Median 2.9%). The company's profitability metrics are significantly below industry benchmarks, reflecting both structural operating losses and extraordinary impairment charges. The negative operating margin contrasts starkly with the industry's positive median, indicating severe cost structure challenges.
Financial Health: Equity Ratio 14.4% (Industry Median 56.8%), Current Ratio 0.44x (Industry Median 1.93x), Financial Leverage 6.93 (Industry Median 1.76). The company's financial health is substantially weaker than industry peers, with equity ratio less than one-quarter of the median and current ratio less than one-quarter of typical retail operators. Financial leverage is nearly four times the industry median, indicating extreme debt dependence and fragility.
Efficiency: Asset Turnover 0.485 (Industry Median 0.95), Operating WC Turnover Days -285 days (Industry Median 32 days), Receivables Turnover Days 50.5 days (Industry Median 29.7 days). Asset utilization efficiency is approximately half the industry standard, reflecting underperforming assets and incomplete capital deployment (high CIP balance). Negative working capital cycle is abnormal for retail operations and indicates supplier credit reliance rather than operational efficiency.
Growth: Revenue Growth YoY +19.9% (Industry Median +3.0%). The company's revenue growth substantially exceeds the industry median, driven by M&A-led expansion rather than organic growth. However, this top-line growth has not translated into profitability improvement, contrasting with industry peers who typically maintain positive operating margins during growth phases.
(Industry: Retail (16 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis)
Severe financial distress requiring urgent remediation: The company exhibits multiple indicators of acute financial stress, including negative working capital of 19.2B yen, current ratio of 43.6%, cash coverage of short-term debt at 0.32x, and deeply negative profitability across all levels (operating margin -34.9%, net margin -177.0%). Debt-to-equity ratio of 5.93 and interest coverage of -6.60x indicate that the current capital structure is unsustainable. The 43.7B yen net loss and equity decline from 14.8B yen to 7.3B yen have severely eroded financial cushion. Immediate priorities must include refinancing short-term borrowings of 12.9B yen, raising additional equity capital to restore balance sheet stability, and implementing aggressive cost restructuring to reduce SG&A from 106.6% to below 100% of revenue. Without these actions within the next two quarters, the company faces heightened default risk and potential going concern issues.
M&A-driven expansion strategy has failed to generate returns: The 33.5B yen impairment loss, reduction of goodwill by 84.8%, and writedown of intangible assets by 80.5% reveal that recent acquisitions have not delivered expected synergies or profitability. The Medical segment (acquired mid-2024) operates at -4.0% margin, and the Renewable Energy segment shows -116.6% margin, both consuming capital rather than generating returns. Corporate overhead of 4.1B yen (16.6% of revenue) associated with integration has further burdened results. The core Restaurant segment margin deteriorated to -0.5% from prior profitability, suggesting management bandwidth has been diverted from core operations. This pattern indicates poor strategic fit or execution in M&A and necessitates strategic review to divest non-core assets, refocus on restaurant turnaround, and halt further expansion until profitability is restored.
Revenue growth without profit conversion highlights structural cost issues: Despite 19.9% revenue growth significantly exceeding the retail industry median of 3.0%, the company posted widening operating losses as SG&A expenses increased 46.1% YoY and exceeded revenue. This disconnect between top-line and bottom-line suggests the business model lacks scalability and that variable costs are misaligned with revenue drivers. The persistence of high fixed corporate costs and segment-level losses across all three divisions indicates that growth has been value-destructive. Stakeholders should monitor quarterly progress on SG&A reduction targets, segment-level margin improvement (particularly Restaurant and Medical), and conversion of construction in progress (6.0B yen) into revenue-generating assets. Failure to demonstrate margin inflection within two quarters would confirm that the business requires fundamental restructuring or capital injection beyond management's current capacity.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.